Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection

Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection Article

sustainable development goals

SDG 03: Good Health and Well-being

publication date

February 1, 2018

webpage

Web of Science

published in

JOURNAL OF DRUGS IN DERMATOLOGY Journal

start page

168

end page

172

volume

17

issue

2